O'Shaughnessy Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.18M | Sell |
73,765
-7,620
| -9% | -$225K | 0.01% | 736 |
|
2025
Q1 | $2.43M | Buy |
81,385
+675
| +0.8% | +$20.1K | 0.02% | 631 |
|
2024
Q4 | $2.31M | Buy |
80,710
+8,475
| +12% | +$243K | 0.02% | 613 |
|
2024
Q3 | $2.74M | Buy |
72,235
+8,635
| +14% | +$328K | 0.02% | 556 |
|
2024
Q2 | $2.05M | Buy |
63,600
+17,865
| +39% | +$575K | 0.02% | 597 |
|
2024
Q1 | $1.78M | Buy |
45,735
+28,100
| +159% | +$1.09M | 0.02% | 619 |
|
2023
Q4 | $543K | Buy |
17,635
+6,126
| +53% | +$189K | 0.01% | 973 |
|
2023
Q3 | $257K | Buy |
11,509
+1,440
| +14% | +$32.2K | ﹤0.01% | 1184 |
|
2023
Q2 | $216K | Sell |
10,069
-7,422
| -42% | -$159K | ﹤0.01% | 1176 |
|
2023
Q1 | $420K | Buy |
+17,491
| New | +$420K | 0.01% | 925 |
|
2021
Q4 | – | Sell |
-1,652
| Closed | -$33K | – | 1494 |
|
2021
Q3 | $33K | Hold |
1,652
| – | – | ﹤0.01% | 1792 |
|
2021
Q2 | $39K | Hold |
1,652
| – | – | ﹤0.01% | 1663 |
|
2021
Q1 | $39K | Sell |
1,652
-3,219
| -66% | -$76K | ﹤0.01% | 1474 |
|
2020
Q4 | $98K | Sell |
4,871
-3,706
| -43% | -$74.6K | ﹤0.01% | 1072 |
|
2020
Q3 | $179K | Sell |
8,577
-1,579
| -16% | -$33K | 0.01% | 735 |
|
2020
Q2 | $178K | Sell |
10,156
-1,209
| -11% | -$21.2K | 0.01% | 676 |
|
2020
Q1 | $186K | Buy |
+11,365
| New | +$186K | 0.01% | 488 |
|